Elevated Plasma Moxifloxacin Concentrations and SLCO1B1 g.-11187G>A Polymorphism in Adults with Pulmonary Tuberculosis

Antimicrobial Agents and Chemotherapy
Marc WeinerWilliam R Mac Kenzie

Abstract

Moxifloxacin exhibits concentration-dependent prolongation of human QTc intervals and bactericidal activity against Mycobacterium tuberculosis However, moxifloxacin plasma concentrations are variable between patients. We evaluated whether human gene polymorphisms affect moxifloxacin plasma concentrations in tuberculosis patients from two geographic regions. We enrolled a convenience sample of 49 adults with drug-sensitive pulmonary tuberculosis from Africa and the United States enrolled in two treatment trials of moxifloxacin as part of multidrug therapy. Pharmacokinetic parameters were evaluated by noncompartmental techniques. Human single-nucleotide polymorphisms of transporter genes were evaluated by analysis of covariance (ANCOVA) on moxifloxacin exposure and the peak (maximum) concentration (Cmax). The moxifloxacin area under the concentration-time curve from 0 to 24 h (AUC0-24) and Cmax were significantly increased by the drug milligram-per-kilogram dosage and the genotype of variant g.-11187G>A in the SLCO1B1 gene (rs4149015) but not by geographic region. The median moxifloxacin AUC0-24 was 46% higher and the median Cmax was 30% higher in 4 (8%) participants who had the SLCO1B1 g.-11187 AG genotype than in 45 participant...Continue Reading

References

Jun 26, 1999·The Journal of Antimicrobial Chemotherapy·H Stass, D Kubitza
Dec 22, 1999·Pacing and Clinical Electrophysiology : PACE·K Hnatkova, M Malik
May 7, 2002·The Pharmacogenomics Journal·L IyerM J Ratain
Jun 1, 2002·Journal of the American College of Cardiology·Anthony R MagnanoDaniel M Bloomfield
Jun 20, 2003·The Pharmacogenomics Journal·C Guillemette
Mar 17, 2005·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Masaya TachibanaToshiharu Horie
May 6, 2006·American Journal of Respiratory and Critical Care Medicine·William J BurmanRichard E Chaisson
May 23, 2007·Antimicrobial Agents and Chemotherapy·Marc WeinerAndrew Vernon
Sep 21, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·H M J NijlandR E Aarnoutse
Feb 25, 2009·Clinical Pharmacology and Therapeutics·D M BloomfieldJ A Wagner
May 2, 2009·American Journal of Respiratory and Critical Care Medicine·Susan E DormanUNKNOWN Tuberculosis Trials Consortium
May 20, 2009·Journal of Clinical Pharmacology·Marek MalikPeter Smetana
Jul 28, 2010·Antimicrobial Agents and Chemotherapy·Marc WeinerAndrew Vernon
Feb 12, 2011·The European Respiratory Journal·A D PrangerJ W C Alffenaar
Jun 22, 2012·Drugs in R&D·Paul M TulkensFrank Kruesmann
Sep 10, 2014·The New England Journal of Medicine·Stephen H GillespieUNKNOWN REMoxTB Consortium
Oct 23, 2014·The New England Journal of Medicine·Amina JindaniUNKNOWN RIFAQUIN Trial Team
Feb 5, 2015·The New England Journal of Medicine·Stephen H GillespieUNKNOWN REMoxTB Consortium
Feb 5, 2015·The New England Journal of Medicine·Pierre O SellierJean-François Bergmann
Apr 11, 2015·The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·E HarauszJ Furin
Mar 24, 2017·The European Respiratory Journal·Dennis FalzonKarin Weyer
Jul 26, 2017·Journal of Clinical Pharmacology·Anushka NaidooNesri Padayatchi

❮ Previous
Next ❯

Citations

Dec 7, 2018·Expert Review of Anti-infective Therapy·Helen McIlleron, Maxwell T Chirehwa
May 7, 2020·Applied Microbiology and Biotechnology·Adetomiwa A AdenijiDu Toit Loots
Aug 23, 2020·International Journal of Molecular Sciences·Gabriele StoccoGiuliana Decorti

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

© 2022 Meta ULC. All rights reserved